Ameriflex Group Inc. Raises Holdings in UnitedHealth Group Incorporated $UNH

Ameriflex Group Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,938 shares of the healthcare conglomerate’s stock after buying an additional 92 shares during the period. Ameriflex Group Inc.’s holdings in UnitedHealth Group were worth $587,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Retirement Planning Group LLC lifted its position in shares of UnitedHealth Group by 5.1% during the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after buying an additional 21 shares during the last quarter. Net Worth Advisory Group lifted its holdings in UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after purchasing an additional 21 shares in the last quarter. Bensler LLC lifted its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock worth $3,637,000 after purchasing an additional 22 shares in the last quarter. Lakeridge Wealth Management LLC lifted its holdings in UnitedHealth Group by 5.8% during the 1st quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock worth $220,000 after purchasing an additional 23 shares in the last quarter. Finally, Broadway Wealth Solutions Inc. lifted its holdings in UnitedHealth Group by 2.1% during the 1st quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate’s stock worth $603,000 after purchasing an additional 24 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $360.17 on Friday. The business’s 50-day moving average price is $307.84 and its 200-day moving average price is $355.58. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market capitalization of $326.20 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analyst Ratings Changes

A number of brokerages recently issued reports on UNH. Truist Financial increased their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Barclays boosted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Bank of America boosted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Oppenheimer cut their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.